Search Results

NHW formed the majority in this group (p<0.001). NHW formed over half of accrued pts in every Rx center (86% comprehensive community cancer, 78% academic, 75% community cancer, and 72% integrated network cancer center). Of the non-White pts, majority

Child’s Experience When a Parent has Cancer” was moderated by Lillie D. Shockney, RN, BS, MAS. It is often recognized that cancer in an individual is a family and a community disease, and no person in the family and community is impacted more than the

Numune Teaching Hospital, Turkey Call for Correspondence JNCCN is committed to providing a forum to enhance collaboration between academic medicine and the community physician. We welcome comments about the NCCN Clinical Practice Guidelines in

conducted in spring of 2019 with primary care providers (n=6), oncology providers (n=10), oncology nurses (n=5), cancer hospital social workers (n=6), and community health workers (n=11). The focus groups were audio recorded and transcribed. Qualitative

both Healing therapies by understanding changes of stress-related biofeedback responses amongst BCSs. Methods: This cross-sectional, randomized trial was conducted to compare therapeutic healing differences. Twenty-two community BCSs (Average age: 59

INTRODUCTION : Telemedicine retains potential for increasing access to specialty providers in underserved and rural communities. COVID-19 accelerated adoption of tele-healthcare beyond rural populations, serving as a primary modality of patient

-based initiatives to improve patient care and outcomes in renal cell carcinoma and hematologic malignancies. The intent of the RFP is to encourage academic and community-based organizations to submit proposals describing concepts and ideas for design and

Society of Clinical Oncology (ASCO) and the National Community Oncology Dispensing Association (NCODA) developed The Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards as a new methodology to support and evaluate medically

the central nervous system (CNS). Although advances in clinical care options for patients have been somewhat limited, the community has seen tremendous progress in the molecular understanding of the disease and how these alterations promote cellular

. NCCN welcomes original abstracts from investigators in the general oncology community; submissions will be accepted from NCCN Member Institutions, academic institutions, teaching and community hospitals, and industry. Topics may fall into the general